HomeCategoryNewsSingapore: Biolidics shares jump on Covid-19 test approval

Singapore: Biolidics shares jump on Covid-19 test approval

-

Diagnostics company Biolidics has seen its share price jump 35% since its rapid test kit for Covid-19 has been accepted for sale in a number of countries. Earlier this week,…

Subscription required

This content is for Subscribers only. To access 4,800+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?
Adrian Murdoch
Adrian Murdoch
Adrian is a financial editor and journalist with more than 25 years of experience. He was the winner of the State Street Best Editorial Comment of the Year at the UK Institutional Press Awards 2023 and CFA UK ESG, Climate and Sustainable Investing Journalism Award 2023. He is the former editor of Capital Monitor at New Statesman Media, Healthcare Markets International in London (PPA Independent Publisher Awards finalist for Launch of the Year 2019) and international editor at FinanceAsia. A former Senior Correspondent for Reuters Insider Television in Frankfurt, and Screens Editor, Asia, for International Financing Review in Singapore, Adrian started his career at World Link, the magazine of the World Economic Forum.
Related Articles
More From Author

Subscription required

This content is for Subscribers only. To access 4,800+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?

Subscription required

This content is for Subscribers only. To access 4,800+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?
Advertisement

Related Resources

Related Events